FGF-19 Antibody (MM0285-4G16) - Azide and BSA Free Summary
| Immunogen |
Human recombinant FGF-19 |
| Isotype |
IgG1 |
| Clonality |
Monoclonal |
| Host |
Mouse |
| Gene |
FGF19 |
| Purity |
Protein G purified |
| Innovator's Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase. |
Applications/Dilutions
| Dilutions |
- Immunohistochemistry 1:20-100
- Immunohistochemistry-Paraffin 1:50-1:100
- Western Blot 1:500-1:1000
|
Packaging, Storage & Formulations
| Storage |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. |
| Buffer |
Lyophilized from a 0.2 um filtered solution in PBS. 0.025 mg size is provided in liquid form, PBS |
| Preservative |
No Preservative |
| Concentration |
LYOPH |
| Purity |
Protein G purified |
| Reconstitution Instructions |
Reconstitute with sterilized PBS to a final concentration of 0.5 mg/ml. |
Alternate Names for FGF-19 Antibody (MM0285-4G16) - Azide and BSA Free
Background
FGF19 (fibroblast growth factor 19), belongs to the FGF family which are involved in cell growth, tissue repair, embryonic development and a number of other biological processes. FGF19 stimulates glucose in adipocytes and is involved in regulating bile acid homeostasis and metabolic state in an endocrine fashion. FGF19 is known to have interactions with FGFR4, FGF1, FGF18, FGF20 and FGF23. FGF19 is currently being studied for research on the following diseases and disorders: diarrhea, obesity, carcinoma insulin resistance, hepatitis and atherosclerosis.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are
guaranteed for 1 year from date of receipt.
Customers Who Viewed This Item Also Viewed...
Species: Hu
Applications: CyTOF-ready, Flow, ICC, IHC, WB
Species: Hu
Applications: DirELISA, IHC, IP, WB
Species: Hu
Applications: ICC
Species: Mu, Rt
Applications: ELISA
Species: Mu
Applications: IHC
Species: Ha, Hu, Pm, Mu, Pm, Rb, Rt
Applications: ICC/IF, IHC, IHC-P
Species: Mu
Applications: IHC
Species: Bv, Hu, Mu
Applications: CyTOF-ready, ICC, IHC, ICFlow
Species: Hu
Applications: BA
Species: Hu, Pm, Mu, Rt
Applications: ELISA, Flow, ICC/IF, IHC, IHC-P, WB
Species: Mu
Applications: WB
Species: Bv, Hu
Applications: ELISA, ICC/IF, IHC, IHC-P, S-ELISA, WB
Species: Hu, Mu
Applications: BA
Species: Hu
Applications: DirELISA, IP, WB
Species: Mu
Applications: ELISA, IHC, WB
Species: Hu, Pm, Mu, Rt
Applications: Flow, ICC/IF, IHC, IHC-P, WB
Species: Hu, Mu, Rt
Applications: IHC, KO, WB
Species: Hu
Applications: BA
Publications for FGF-19 Antibody (NBP2-12299) (0)
There are no publications for FGF-19 Antibody (NBP2-12299).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for FGF-19 Antibody (NBP2-12299) (0)
There are no reviews for FGF-19 Antibody (NBP2-12299).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
Video Protocols
FAQs for FGF-19 Antibody (NBP2-12299). (Showing 1 - 1 of 1 FAQ).
-
I just received FGF19 Cat# NBP2-12299 and the mAb is 0.1 mg powder. How do you recommend reconstituting this antibody?
- You should reconstitute NBP2-12299 with 200 ul sterile PBS so the final concentration is 500 ug/ml.
Secondary Antibodies
| |
Isotype Controls
|
Additional FGF-19 Products
Research Areas for FGF-19 Antibody (NBP2-12299)
Find related products by research area.
|
Blogs on FGF-19
![Immunocytochemistry FGFR4 Antibody (240929) [Unconjugated]](https://images.novusbio.com/images2/FGF_R4_MAB6852_Immunocytochemistry_11692.jpg)
![Immunohistochemistry FGFR4 Antibody (240929) [Unconjugated]](https://images.novusbio.com/images2/FGF_R4_MAB6852_Immunohistochemistry_11804.jpg)
![Western Blot FGFR4 Antibody (240929) [Unconjugated]](https://images.novusbio.com/images2/FGF_R4_MAB6852_Flow_Cytometry_18630.jpg)
![FXR/NR1H4 Antibody (A9033A) [Unconjugated]](/sites/all/modules/enterprise-tech/et_datasheets/images/novus_guarantee.png "FXR/NR1H4 Antibody (A9033A) [Unconjugated]")
![Immunocytochemistry CYP7A1 Antibody (946902) [Unconjugated]](https://images.novusbio.com/images2/CYP7A1_MAB9120_Immunocytochemistry__Immunofluorescence_19938.jpg)
![N/A FGF-21 [HRP]](https://images.novusbio.com/images2/FGF-21_MF2100_ELISA_265.jpg)
![N/A FGF-21 [HRP]](https://images.novusbio.com/images2/FGF-21_MF2100_ELISA_266.jpg)
![N/A FGF-21 [HRP]](https://images.novusbio.com/images2/DATA_FGF21_MF2100_ELISA_972.jpg)
![Immunohistochemistry FGF-23 Antibody (283507) [Unconjugated]](https://images.novusbio.com/images2/FGF23_MAB26291_Immunohistochemistry_17626.jpg)
![Immunohistochemistry FGF-23 Antibody (283507) [Unconjugated]](https://images.novusbio.com/images/mab26291_mouse-fgf-23-mab-clone-283507-41202412512640.jpg)
![Western Blot FGF-23 Antibody (283507) [Unconjugated]](https://images.novusbio.com/images/mab26291_mouse-fgf-23-mab-clone-283507-41202412514876.jpg)
![Immunocytochemistry Insulin Antibody (182410) [Unconjugated]](https://images.novusbio.com/images2/Insulin_MAB1417_Immunocytochemistry_9376.jpg)
![Immunohistochemistry Insulin Antibody (182410) [Unconjugated]](https://images.novusbio.com/images2/mab1417_human-bovine-mouse-insulin-mab-clone-182410-immunohistochemistry-308202115145.jpg)
![SDS-PAGE FGF-8 [Unconjugated]](https://images.novusbio.com/images2/FGF-8_423-F8_332.jpg)
![Bioactivity FGF-8 [Unconjugated]](https://images.novusbio.com/images2/FGF8_423F8_1438.jpg)
![Cell Culture FGF-8 [Unconjugated]](https://images.novusbio.com/images/423-f8_recombinant-human-mouse-fgf-8b-protein-cell-culture-1052024145159..jpg)
![Immunohistochemistry Klotho Antibody [Unconjugated]](https://images.novusbio.com/images2/Klotho_AF1819_Immunohistochemistry_6720.jpg)
![Western Blot Klotho Antibody [Unconjugated]](https://images.novusbio.com/images2/Klotho_AF1819_Western_Blot_22658.jpg)
![ELISA Klotho Antibody [Unconjugated]](https://images.novusbio.com/images2/Klotho_AF1819_ELISA_22841.jpg)
![Western Blot ERK2 Antibody [Unconjugated]](https://images.novusbio.com/images2/ERK2_AF1230_Western_Blot_5097.jpg)
![Immunohistochemistry ERK2 Antibody [Unconjugated]](https://images.novusbio.com/images2/ERK2_AF1230_Immunohistochemistry_20696.jpg)
![Knockout Validated ERK2 Antibody [Unconjugated]](https://images.novusbio.com/images2/ERK2_AF1230_Knockout_Validated_22864.jpg)
![SDS-PAGE FGF-4 [Unconjugated]](https://images.novusbio.com/images2/FGF-4_235-F4_472.jpg)
![Bioactivity FGF-4 [Unconjugated]](https://images.novusbio.com/images2/FGF-4_235-F4_483.jpg)
![SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.](https://images.novusbio.com/images/Mouse-IgG1-Isotype-Control-MG1-SDS-Page-NBP1-97005-img0002.jpg "SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.")